| Dr William Lighthart, MD | |
|
555 E Broadway Ave, Jackson, WY 83001-8640 | |
| (307) 733-3900 | |
| (307) 732-0925 |
| Full Name | Dr William Lighthart |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 24 Years |
| Location | 555 E Broadway Ave, Jackson, Wyoming |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427004647 | NPI | - | NPPES |
| 1336221712 | Other | WY | 830322741 |
| 83-0322741 | Other | WY | 1336221712 |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207XS0114X | Orthopaedic Surgery - Adult Reconstructive Orthopaedic Surgery | 036115858 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St John's Home Care | Jackson, WY | Home health agency |
| St Johns Medical Center | Jackson, WY | Hospital |
| Star Valley Medical Center | Afton, WY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedics Of Jackson Hole Pc | 9436042322 | 10 |
News Archive
Drug studies financed by pharmaceutical companies frequently show positive results in favour of the sponsor. In the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2010; 107(16): 279-85), a research group headed by the Chairman of the Drug Commission of the German Medical Association, Prof. Wolf-Dieter Ludwig, describes the influence of sponsoring on the results, protocol and quality of drugs studies.
Vital Images, Inc., a leading provider of advanced visualization and analysis software, announced today that it is collaborating with Arkansas Children's Hospital of Little Rock, Ark., to develop a Vitrea® pediatric cardiac application. The software is an advanced visualization tool designed specifically to meet the unique cardiac features and patient care requirements presented by pediatric patients.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 1b clinical study of PRM-151 to explore the safety, tolerability, pharmacokinetics, and phamacodynamics of PRM-151 in the treatment of patients with idiopathic pulmonary fibrosis.
Although many blame the health law for all recent health care cost increases, trends that bump up the cost of care were in place before the law was enacted and are being driven up even more by routine costs, some say.
Multiple myeloma is one of the most common blood cancers, and at present considered to be incurable. In a new study from Uppsala University, researchers now present a conceptually new model for the development and progression of multiple myeloma. The study was done in collaboration with Vrije Universitet Brussels and is published in the July edition of the on-line journal PLoS ONE.
› Verified 1 days ago
| Entity Name | Orthopaedics Of Jackson Hole Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336221712 PECOS PAC ID: 9436042322 Enrollment ID: O20040204000890 |
News Archive
Drug studies financed by pharmaceutical companies frequently show positive results in favour of the sponsor. In the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2010; 107(16): 279-85), a research group headed by the Chairman of the Drug Commission of the German Medical Association, Prof. Wolf-Dieter Ludwig, describes the influence of sponsoring on the results, protocol and quality of drugs studies.
Vital Images, Inc., a leading provider of advanced visualization and analysis software, announced today that it is collaborating with Arkansas Children's Hospital of Little Rock, Ark., to develop a Vitrea® pediatric cardiac application. The software is an advanced visualization tool designed specifically to meet the unique cardiac features and patient care requirements presented by pediatric patients.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 1b clinical study of PRM-151 to explore the safety, tolerability, pharmacokinetics, and phamacodynamics of PRM-151 in the treatment of patients with idiopathic pulmonary fibrosis.
Although many blame the health law for all recent health care cost increases, trends that bump up the cost of care were in place before the law was enacted and are being driven up even more by routine costs, some say.
Multiple myeloma is one of the most common blood cancers, and at present considered to be incurable. In a new study from Uppsala University, researchers now present a conceptually new model for the development and progression of multiple myeloma. The study was done in collaboration with Vrije Universitet Brussels and is published in the July edition of the on-line journal PLoS ONE.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William Lighthart, MD Po Box 10490, Jackson, WY 83002-0490 Ph: (307) 733-3900 | Dr William Lighthart, MD 555 E Broadway Ave, Jackson, WY 83001-8640 Ph: (307) 733-3900 |
News Archive
Drug studies financed by pharmaceutical companies frequently show positive results in favour of the sponsor. In the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2010; 107(16): 279-85), a research group headed by the Chairman of the Drug Commission of the German Medical Association, Prof. Wolf-Dieter Ludwig, describes the influence of sponsoring on the results, protocol and quality of drugs studies.
Vital Images, Inc., a leading provider of advanced visualization and analysis software, announced today that it is collaborating with Arkansas Children's Hospital of Little Rock, Ark., to develop a Vitrea® pediatric cardiac application. The software is an advanced visualization tool designed specifically to meet the unique cardiac features and patient care requirements presented by pediatric patients.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 1b clinical study of PRM-151 to explore the safety, tolerability, pharmacokinetics, and phamacodynamics of PRM-151 in the treatment of patients with idiopathic pulmonary fibrosis.
Although many blame the health law for all recent health care cost increases, trends that bump up the cost of care were in place before the law was enacted and are being driven up even more by routine costs, some say.
Multiple myeloma is one of the most common blood cancers, and at present considered to be incurable. In a new study from Uppsala University, researchers now present a conceptually new model for the development and progression of multiple myeloma. The study was done in collaboration with Vrije Universitet Brussels and is published in the July edition of the on-line journal PLoS ONE.
› Verified 1 days ago
Mary C Neal, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 945 W Broadway, Jackson, WY 83001 Phone: 307-734-5999 Fax: 307-734-0345 | |
Dr. Blane A Woodfin, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 555 E Broadway, Jackson, WY 83001 Phone: 307-733-3900 Fax: 307-732-0925 | |
Dr. James R Champa, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 555 E Broadway, Jackson, WY 83001 Phone: 307-733-3900 Fax: 307-732-0925 | |
Joshua D. Beck, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 555 East Broadway, Jackson, WY 83001 Phone: 307-733-3900 Fax: 307-732-0925 | |
Dr. Peter E Rork, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 555 E Broadway, Jackson, WY 83001 Phone: 307-733-3900 Fax: 307-732-0925 | |
Christopher Clayton Hills, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 555 E Broadway Ave, Jackson, WY 83001 Phone: 307-733-3900 Fax: 307-732-0925 |